Abstract
This guest commentary introduces “The Neuroimmune Pharmacology of SARS-CoV-2,” a special theme issue for The Journal of Neuroimmune Pharmacology led by the Society on NeuroImmune Pharmacology. The issue builds on the Society’s Virtual Workshop on COVID-19 held April 9, 2021. Graphical abstract: Top row from left: Drs. Santosh Kumar, Sowmya Yelamanchili, Pankaj Seth, Jean M. Bidlack; Bottom row from left: Drs. Gurudutt Pendyala, Sanjay Maggirwar, and Sulie L. Chang.[Figure not available: see fulltext.].
Author supplied keywords
Cite
CITATION STYLE
Kumar, S., Yelamanchili, S., Seth, P., Bidlack, J. M., Pendyala, G., Maggirwar, S., & Chang, S. L. (2021, December 1). The Neuroimmune Pharmacology of SARS-CoV-2. Journal of Neuroimmune Pharmacology. Springer. https://doi.org/10.1007/s11481-021-10038-z
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
